Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer

American Journal of Gastroenterology

Volumn 106, Issue 6, 2011, Pages 1110-1118

  Herbst, Andreas ^a   Rahmig, Konstanze ^a   Stieber, Petra ^b   Philipp, Alexander ^a   Jung, Andreas ^a   Ofner, Andrea ^a   Crispin, Alexander ^c   Neumann, Jens ^a   Lamerz, Rolf ^a   Kolligs, Frank T ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Clinical Chemistry   (Germany)

^c Institute of Medical Informatics Biometry and Epidemiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROGENIN 1; TUMOR MARKER; VIMENTIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; EARLY CANCER; FEMALE; HUMAN; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; SERUM;

ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PILOT PROJECTS; REFERENCE VALUES; ROC CURVE; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79957971986     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.6     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
2. Selby JV, Friedman GD, Quesenberry CPJ et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-7.
3. Winawer SJ, Zauber AG, Ho MN e t al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81. (Pubitemid 24015040)
4. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95. (Pubitemid 351615355)
5. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009; 104: 739-50.
6. Schmiegel W, Reinacher-Schick A, Arnold D et al. Update S3-guideline " colorectal cancer " 2008]. Z Gastroenterol 2008; 46: 799-840.
7. Harewood GC, Wiersema MJ, Melton L Jr. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186-94. (Pubitemid 35428814)
8. Ziegler M, Schubring-Giese B, Buhner M et al. Attitude to secondary prevention and concerns about colonoscopy are independent predictors of acceptance of screening colonoscopy. Digestion 2010; 81: 120-6.
9. Kahi CJ, Rex DK, Imperiale TF. Screening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature. Gastroenterology 2008; 135: 380-99.
10. Imperiale TF, Ransohoff DF, Itzkowitz SH et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-14. (Pubitemid 39665324)
11. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128 : 683-92. (Pubitemid 46273572)
12. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99: 3740-5. (Pubitemid 34252176)
13. Baylin SB, Esteller M, Rountree MR et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001; 10: 687-92. (Pubitemid 32331576)
14. Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007; 56: 140-8. (Pubitemid 46044900)
15. Lenhard K, Bommer GT, Asutay S et al. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 2005; 3: 142-9. (Pubitemid 40220309)
16. Muller HM, Widschwendter M. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids. Expert Rev Mol Diagn 2003; 3: 443-58. (Pubitemid 36859292)
17. Glockner SC, Dhir M, Yi JM et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009; 69: 4691-9.
18. Itzkowitz SH, Jandorf L, Brand R et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007; 5: 111-7. (Pubitemid 46096834)
19. Hundt S, Haug U, Brenner H. Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 2007; 16: 1935-53. (Pubitemid 47621167)
20. deVos T, Tetzner R, Model F et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009; 55: 1337-46.
21. Ebert MP, Model F, Mooney S et al. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology 2006; 131: 1418-30. (Pubitemid 44708938)
22. Herbst A, Wallner M, Rahmig K et al. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence. Eur J Gastroenterol Hepatol 2009; 21: 565-9.
23. Wallner M, Herbst A, Behrens A et al. Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res 2006; 12: 7347-52. (Pubitemid 46095407)
24. Eads CA, Danenberg KD, Kawakami K et al. MethyLight: a highthroughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28: E32.
25. Eads CA, Lord RV, Wickramasinghe K et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001; 61: 3410-8. (Pubitemid 32695034)
26. Weisenberger DJ, Campan M, Long TI et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33: 6823-36. (Pubitemid 41830488)
27. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23: 29-39. (Pubitemid 38221595)
28. Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol 2005; 32: 521-30.
29. Weisenberger DJ, Siegmund KD, Campan M et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-93. (Pubitemid 43980599)
30. Morikawa T, Kato J, Yamaji Y et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population . Gastroenterology 2005; 129: 422-8. (Pubitemid 41096630)
31. Schoenfeld P, Cash B, Flood A et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005; 352: 2061-8. (Pubitemid 40664307)
32. Leon SA, Shapiro B, Sklaroff DM et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37: 646-50. (Pubitemid 8051621)
33. Vasioukhin V, Anker P, Maurice P et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 1994; 86: 774-9. (Pubitemid 24194434)
34. Sorenson GD, Pribish DM, Valone FH et al. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev 1994; 3: 67-71.
35. Lindforss U, Fredholm H, Papadogiannakis N et al. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma. Cancer 2000; 88: 2661-7. (Pubitemid 30417925)
36. Loft on-Day C, Model F, Devos T et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008; 54: 414-23. (Pubitemid 351302625)
37. Li M, Chen WD, Papadopoulos N et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009; 27: 858-63.
38. Ahlquist DA, Sargent DJ, Loprinzi CL et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008; 149: 441-50, W81.